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F2α at the Time of AI Fails to Improve 
Pregnancy Rates of Lactating Dairy Cows
J.S. Stevenson, J.A. Sauls, and L. Mendonça
Summary
In two experiments we tested the hypothesis that administering 10 mg of prostaglandin 
F2α (PGF) to lactating dairy cows concurrent with timed artificial insemination would 
increase pregnancy outcome. In three herds with 2,135 inseminations, we failed to 
demonstrate a positive effect on pregnancy per AI. Although a trend was observed in 
experiment 1, with more cows in experiment 2, the PGF treatment failed to improve 
pregnancy outcomes. 
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Introduction
Treatment of domestic livestock with prostaglandin F2α (PGF) administered intrave-
nously, intramuscularly, or in the uterus concurrent with AI to improve conception 
has been a subject of recurring research since the early 1990s. Pregnancy outcomes have 
been improved in four studies, but not in three others. Studies in which positive preg-
nancy outcomes have been most consistent seem to have involved dairy cows inseminat-
ed at a timed AI near the peak of lactation in negative energy balance, in cows with less 
than acceptable reproductive performance (such as repeat breeders), and where stress 
factors negatively impact ovulation.
Apart from its primary luteolytic role to regress the corpus luteum and induce estrus, 
PGF has multiple actions on the female reproductive system in cattle and other farm 
animals. Treatment with PGF concurrent with AI could increase pregnancy rates by:
• increasing uterine contractility, thereby enhancing sperm transport;
• inducing LH release via a luteolysis-independent mechanism, thereby facilitating 
the ovulatory process;
• hastening luteal regression in cows that may otherwise have delayed or incomplete 
luteolysis at AI, thereby creating a low progesterone environment conducive for 
optimal gamete transport;
• inducing release of growth hormone (GH) and subsequent GH-induced insulin-
like growth factor-1 secretion, known to increase fertility of lactating dairy cows 
during the pre- and peri-implantation periods resulting in improvements in con-
ceptus development and a reduction in embryonic mortality;
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• increasing the number of cows with a corpus luteum post-AI;
• increasing post-AI corpus luteum size and concentrations of progesterone; and (or)
• inducing secretion of oxytocin that may stimulate uterine contractions and sup-
port sperm transport because sperm transport has been improved by adding to 
semen or administering to females such compounds as PGF, oxytocin, estradiol, 
phenylephrine, or ergonovine.
Our hypothesis was that administering 10 mg of PGF (2 cc Lutalyse, dinoprost tro-
methamine sterile solution, Zoetis Animal Health, Whitehouse Station, NJ) concur-
rent with timed AI will increase pregnancy outcomes in lactating dairy cows. Our objec-
tives were to assess ovarian characteristics and pregnancy outcomes in lactating dairy 
cows in response to administration of PGF.
Experimental Procedures
Experiment 1 
We conducted this study with 287 lactating dairy cows in the Kansas State University 
Dairy Teaching and Research Center in a completely randomized design with 2 treat-
ments. Cows diagnosed not pregnant (day 0) at 30 to 36 days after AI were body scored 
(1 = thin and 5 = fat), received GnRH at the open diagnosis, 25 mg of PGF on day 
5 (second PGF on day 6) or on day 7, and GnRH at 56 h after the first or only PGF 
injection. Cows were stratified by parity (primiparous vs. multiparous) and assigned 
randomly to receive 10 mg PGF (n = 147) at timed AI (72 h after the first or only PGF 
injection) or served as untreated controls (n = 140).
Ovaries were scanned via transrectal ultrasonography 72 h before timed AI to charac-
terize number and diameter of all ovarian follicles and re-examined 13 days after timed 
AI to determine incidence of ovulation, ovulation rate, and total volume of luteal tissue 
per CL. Blood samples were collected 3 days before timed AI (day -3), at timed AI (day 
0), and on day 13 after timed AI to determine progesterone concentration. Pregnancy 
diagnosis was conducted at 30 to 36 days after AI.
Concentration of progesterone and volume of luteal tissue on day 13 were analyzed 
using procedure MIXED with the fixed effects of treatment, and with days in milk 
and BCS as covariates. Luteal regression was verified by changes in blood progesterone 
concentration between days -3 and 0. Differences in ovulation rate and progesterone 
were interpreted as direct effects of PGF treatment on functions of the preovulatory 
follicle(s) and subsequent forming CL.
Experiment 2
We conducted this study with 782 cows in one dairy operation and 1,066 cows in a sec-
ond dairy. Cows were milked thrice daily. Cows with odd-numbered ear tags received 
no treatment (control) and even-numbered ear tag cows receiving (i.m.) 10 mg PGF 
concurrent with timed AI as in experiment 1. Cows were treated after first and repeat 
inseminations. Initial pregnancy diagnoses occurred between days 32 and 35 and were 
verified between days 63 and 68 after timed AI. Body condition scores were assessed 
biweekly so they were assigned 3 days before or 4 days after timed AI and treatment.
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Outcome variables included pregnancy rates per timed AI and intervening embryo loss. 
Nuisance variables include lactation number, days in milk at timed AI, body condition 
score at timed AI, herd, and season. Binomial outcomes were modeled using logistic 
regression in procedure GLIMMIX in SAS. The model included the fixed effects of 
treatment (PGF vs. control), lactation number (1 vs. 2+), treatment × lactation num-
ber, with days in milk and BCS as covariates. Herd was treated as a random variable, 
with treatment differences tested by the treatment within herd variance.
Results and Discussion
Experiment 1 
Percentage of cows in which luteolysis had occurred (progesterone ≤ 0.5) before treat-
ment at timed AI did not differ between treated and control cows (93 vs. 89%). Inci-
dence of single ovulation after timed AI exceeded 95% and did not differ between treat-
ments (Table 1). In contrast, treatment with PGF reduced (P < 0.05) the proportion of 
cows with double ovulation compared with controls. Concentrations of progesterone at 
AI and volume of the luteal tissue 13 days after timed AI did not differ between treat-
ments (Table 1). Pregnancy per AI at days 32 and 80 tended to be 10 and 18% greater 
for cows treated with PGF, but did not differ between treatments (Table 1).
Experiment 2
Test-day daily milk yield (92 vs. 86 lb), days in milk at treatment (114 vs. 100), and per-
centage of first-lactation cows enrolled in the study (38 vs. 34%) for herds 1 and 2 were 
similar. Pregnancy per AI at 32 to 35 days and at 63 to 68 days did not differ between 
treatments. Pregnancy loss also did not differ between treatments.
Despite a recent report that 10 mg of PGF increased pregnancy outcomes in 1 herd 
of dairy cows in Canada, we could not corroborate those results. The fact that PGF 
reduced double ovulation and tended to increase pregnancy outcome in experiment 
1 is evidence for a potential biologic effect. Inconsistency in the pregnancy outcome, 
however, is consistent with other studies. In a study in which PGF at the time of AI 
increased pregnancy outcome, it also increased luteal tissue and progesterone concentra-
tion 13 days after treatment. Results in experiment 1 failed to verify those findings.
In conclusion, results of our study fail to demonstrate a pregnancy outcome benefit of 
treating cows with a small dose of PGF at AI.
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Table 1. Ovarian responses and pregnancy outcomes after treatment of lactating dairy 
cows with 10 mg PGF2α at AI (experiment 1)
Treatment1
Item Control PGF2α
Cows, no 147 140
Single ovulation, % 95.6 95.2
Multiple ovulation, % 24.2 13.8*
Progesterone,2 ng/mL 5.8 ± 0.3 6.1 ± 0.3
Volume of CL,2 cm3 9.1 ± 0.5 9.3 ± 0.5
Pregnancy per AI at d 32, % 29.2 32.5
Pregnancy per AI at d 80, % 24.9 30.4
*Differs from control (P < 0.05).
1Cows were treated with 10 mg PGF2α at AI.
2Day 13 after treatment.




No. cows treated 1,066 782
Pregnancy per AI at 32-35 d
Control, % 33.9 (549) 43.1 (362)
PGF2α treatment,
1 % 30.2 (517) 44.1(401)
Pregnancy per AI at 63-68 d
Control, % 32.2 (549) 38.1 (362)
PGF2α treatment,
1 % 27.7 (516) 38.9 (391)
Pregnancy loss
Control, % 4.8 (186) 11.5 (156)
PGF2α treatment,
1 % 7.7 (155) 9.0 (167)
 1Cows were treated with 10 mg PGF2α at AI.
